Subject(s)

COVID-19 Vaccines/therapeutic use , COVID-19/therapy , Immunotherapy, Active/adverse effects , SARS-CoV-2/immunology , Adolescent , Adult , Aged , Aged, 80 and over , COVID-19/epidemiology , COVID-19 Vaccines/adverse effects , Clinical Trials as Topic/methods , Clinical Trials as Topic/organization & administration , Clinical Trials as Topic/standards , Female , Follow-Up Studies , Humans , Immunotherapy, Active/methods , Immunotherapy, Active/statistics & numerical data , Male , Middle Aged , Pandemics , Patient Safety/standards , RNA, Messenger/adverse effects , RNA, Messenger/therapeutic use , SARS-CoV-2/genetics , Treatment Outcome , Young Adult